ScinoPharm Taiwan Ltd Cash Flow Reinvestment Rate
ScinoPharm Taiwan Ltd cash flow reinvestment rate. ScinoPharm Taiwan Ltd (1789) has a Cash Flow Reinvestment Rate of 0.42x as of March 2026, reinvesting NT$83.34 Million (capex NT$83.34 Million ) from operating cash flow of NT$199.47 Million. See how financially flexible is ScinoPharm Taiwan Ltd to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ScinoPharm Taiwan Ltd (2007–2025)
Cash flow reinvestment rate of ScinoPharm Taiwan Ltd from 2007 to 2025. Historical reinvestment intensity for ScinoPharm Taiwan Ltd across 19 annual periods. Explore ScinoPharm Taiwan Ltd (1789) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
ScinoPharm Taiwan Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
ScinoPharm Taiwan Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for ScinoPharm Taiwan Ltd. For the full cash flow conversion analysis, see cash flow conversion of ScinoPharm Taiwan Ltd.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.42x | NT$1.45 Billion | NT$597.11 Million | NT$291.29 Million | ▲ +529.6% |
| 2024 | 0.38x | NT$288.73 Million | NT$750.91 Million | NT$288.73 Million | ▼ -82.8% |
| 2023 | 2.24x | NT$518.00 Million | NT$231.13 Million | NT$284.71 Million | ▲ +244.3% |
| 2022 | 0.65x | NT$503.66 Million | NT$773.79 Million | NT$250.04 Million | ▼ -43.1% |
| 2021 | 1.14x | NT$582.83 Million | NT$509.82 Million | NT$321.32 Million | ▲ +69.6% |
| 2020 | 0.67x | NT$637.86 Million | NT$946.31 Million | NT$183.10 Million | ▲ +354.8% |
| 2019 | 0.15x | NT$116.94 Million | NT$788.95 Million | NT$105.70 Million | ▼ -39.6% |
| 2018 | 0.25x | NT$302.37 Million | NT$1.23 Billion | NT$127.05 Million | ▼ -45.5% |
| 2017 | 0.45x | NT$437.94 Million | NT$971.71 Million | NT$410.93 Million | ▲ +13.6% |
| 2016 | 0.40x | NT$660.84 Million | NT$1.67 Billion | NT$458.52 Million | ▼ -56.4% |
| 2015 | 0.91x | NT$951.79 Million | NT$1.04 Billion | NT$667.58 Million | ▼ -38.1% |
| 2014 | 1.47x | NT$1.31 Billion | NT$888.29 Million | NT$1.02 Billion | ▲ +2.3% |
| 2013 | 1.44x | NT$1.35 Billion | NT$939.47 Million | NT$1.24 Billion | ▲ +60.3% |
| 2012 | 0.90x | NT$881.19 Million | NT$981.55 Million | NT$881.19 Million | ▲ +43.4% |
| 2011 | 0.63x | NT$810.14 Million | NT$1.29 Billion | NT$810.14 Million | ▲ +141.4% |
| 2010 | 0.26x | NT$405.62 Million | NT$1.56 Billion | NT$405.62 Million | ▲ +75.9% |
| 2009 | 0.15x | NT$191.28 Million | NT$1.30 Billion | NT$191.28 Million | ▲ +43.4% |
| 2008 | 0.10x | NT$144.62 Million | NT$1.41 Billion | NT$144.62 Million | ▼ -37.3% |
| 2007 | 0.16x | NT$82.74 Million | NT$504.50 Million | NT$82.74 Million | — |